Time: 0745-0845

Chair: Professor Dlawer Ala’Aldeen, Professor of Clinical Microbiology, University of Nottingham

Presentation Title: Research & training breakfast workshop – Brain storming clinical research careers

Professor of Clinical Microbiology; Head of Molecular Bacteriology and Immunology Group, Faculty of Medicine, Nottingham University. Director of Research, Royal College of Pathologist and Chairman of the RCP/RCPath Infection Research Subcommittee.

Return to the top

Time: 0745-0845

Chair: Professor Jon Friedland, Head of Department of Infectious Diseases and Immunity, Imperial College London

Professor of Infectious Diseases and Head of the Department of Infectious Diseases and Immunity at Imperial College London. In addition, I am Chief of Service for Clinical Infection at Imperial College NHS Trust. I am currently President of the British Infection Society. My main research interests centre around innate immune response and novel diagnostics in tuberculosis. I am Fellow of the Academy of Medical Sciences.

Return to the top

Time: 0745-0845

Speaker: Dr Lisa Cotterill, Director, NIHR Co-ordinating Centre for Research Capacity Development

Presentation Title: NIHR Integrated academic training

Graduated BSc in Biochemistry from the University of Liverpool in 1986 and PhD in renal preservation from the University of London in 1991. She spent several years as a Post-Doctoral Research Fellow at the Medical Research Council Clinical Sciences Centre in London where her research interests included T-cell interactions and immunotherapy in leukaemia. In January 2000, she moved into research management at the Medical Research Council maintaining their portfolio for health services and public health research including research in primary care. Following 2 years as Assistant Director, Lisa became Director of the NIHR Co-ordinating Centre for Research Capacity Development (NIHR CCRCD) in May 2005. The NIHR CCRCD co-ordinates the NIHR R&D Research Capacity Development Programme and is based at the Leeds Innovation Centre in Leeds.

Return to the top

Time: 0915-1015

Speaker: Sir Richard Sykes, Chairman, NHS London

Presentation Title: The evolution of antimicrobial resistance: a Darwinian perspective

Sir Richard Sykes became Chairman of NHS London in December 2008. Before joining NHS London, Sir Richard was Rector of Imperial College London. Prior to Imperial, he had a thirty year career in pharmaceutical industry with Glaxo, subsequently Glaxo Wellcome, where he was Chairman and Chief Executive, and then GlaxoSmithKline which he left as Chairman in 2002. Sir Richard serves on a number of scientific, higher education and government committees both in the UK and abroad. He also holds a number of degrees and awards from institutions both in the UK and overseas. Sir Richard is a Fellow of the Royal Society and Academy of Medical Sciences, an Honorary Fellow of the Royal Academy of Engineering, Royal Society of Chemistry, Royal Pharmaceutical Society, Royal College of Pathologists and Royal College of Physicians. He is a Fellow of Imperial College School of Medicine, King's College London, a Fleming Fellow at Lincoln College and, an Honorary Fellow of the University of Wales, Cardiff and the University of Central Lancashire. He received a knighthood in the 1994 New Year's Honours list for services to the pharmaceutical industry.

Return to the top

Time: 1100-1230

Speaker: Professor Matthew Baylis, Oxenhale Chair of Veterinary Epidemiology, University of Liverpool

Presentation Title: Human impact of Bluetongue

Matthew trained in entomology at Oxford University and then spent four years studying tsetse flies in the wilds of Kenya. This was followed by ten years at the Institute for Animal Health studying the midge vectors of bluetongue and African horse sickness, and scrapie in sheep. In 2005 he moved north and now leads the Liverpool University Climate and Infectious Diseases of Animals group (LUCINDA).

Return to the top

Time: 1100-1230

Speaker: Professor Sarah Randolph, Professor of Parasite Ecology; Tutorial Fellow in Biological Sciences at Christ Church, University of Oxford, Department of Zoology

Presentation Title: Impact of human activities on the risk of zoonotic infections

After graduating from Oxford and gaining a PhD from King’s College London in the early 1970s, I returned to a fixed-term teaching post in the Department of Zoology, Oxford, where I met my husband. Teaching and research, alongside marriage and three children, have been supported by Research Fellowships from Leverhulme Trust, Royal Society, Wellcome Trust, Natural Environment Research Council and, since 2007, open-ended University contract! Over the past decade, I have found quantitative explanations for the persistence of tick-borne encephalitis virus in nature and its distribution. I am currently developing explanations for the recent marked, but highly variable, upsurge in TBE incidence across Europe.

Return to the top

Time: 1100-1230

Speaker: Professor Patrice Courvalin, Institut Pasteur

Presentation title: The ‘Tides’ of Resistance

Patrice Courvalin, M.D., is a Professor at the Institut Pasteur where he directs the French National Reference Center for Antibiotics and is the Head of the Antibacterial Agents Unit since 1983. He is an expert in the genetics and biochemistry of antibiotic resistance in bacteria. In particular, he and his collarborators first described and then elucidated vancomycin reistance in Enterococcus.

Return to the top

Time: 1100-1230

Speaker: Mr Christopher Teale, Veterinary Surgeon, Head of Antimicrobial Resistance, Veterinary Laboratories Agency, UK

Presentation title: Is the tide turning on animal infections?

Chris Teale qualified as a vet from Cambridge and then spent two years in general mixed veterinary practice before joining the Veterinary Investigation Service (now the Veterinary Laboratories Agency). He gained an MSc in Veterinary Microbiology in 1993 from the University of London and now leads the antimicrobial resistance work done at VLA.

Return to the top

Time: 1100-1230

Chair: Mr Tony White, Independent Consultant

Tony White has over 30 years experience in antibacterials research, development, marketing, and communications gained in industry and as an independent consultant . Tony, a microbiologist, has presented at international meetings, published frequently in major journals, has been responsible for the content of over 30 international symposia and associated publications, and has chaired global strategic advisory boards. He is a member of the major ID societies, on the council of BSAC and has worked on WHO and EU strategy teams for appropriate use of antibacterials.

Return to the top

Time: 1100-1230

Speaker: Dr Alan Johnson, Consultant Clinical Scientist, HPA Centre for Infections, London

Title: Is the tide turning on human infections?

Dr Johnson works for the UK Health Protection Agency undertaking surveillance of antibiotic resistance. He also teaches on a number of academic courses on aspects of medical microbiology. He is currently Editor-in-Chief of the Journal of Antimicrobial Chemotherapy.

Return to the top

Time: 1100-1230

Speaker: Dr Susan Dawson, Senior Lecturer, School of Veterinary Science, University of Liverpool

Title: Antibiotic resistance pathogens in animals and man: turning the tide

Susan Dawson is a veterinary surgeon working at the University of Liverpool. Her research interests focus on infectious diseases in particular zoonotic infections and antibacterial resistance. She is a member of the Veterinary Products Committee a scientific advisory committee to Defra, and ARHAI (antibiotic resistance and healthcare associated infections), an advisory committee to the Department of Health.

Return to the top

Time: 1400-1500

Speaker: Dr Rod Escombe, Honorary Research Fellow, Dept Infectious Diseases & Immunity, Hammersmith Campus, Imperial College London

Title: Tuberculosis transmission, infectiousness and infection control

Following hospital posts in infectious diseases and tropical medicine in London, I went to Peru in 2002, staying for 5 years to conduct research into airborne TB transmission. I was awarded a Wellcome Trust Research Training Fellowship, and completed a PhD in 2006. I subsequently worked on TB infection control projects funded by GFATM in Peruvian prisons and hospitals, and with MSF in South Africa. I am now completing my UK training as a GP, on the St Mary’s Hospital London scheme. I plan to return to Peru in 2011 to continue my research on TB infection control.

Return to the top

Time: 1615-1815

Speaker: Professor Robin Patel, Professor of Medicine and Microbiology, Mayo Clinic

Presentation title: Pathogenicity factors and clinical importance of Staphylococcus lugdunensis

Dr. Robin Patel graduated from Princeton University with a BA in Chemistry and from McGill University with an M.D.(C.M.). She completed residencies in Internal Medicine and Microbiology and a fellowship in Infectious Diseases at the Mayo Clinic, following which she joined the staff of Mayo Clinic, where she is currently Professor of Medicine, and Professor of Microbiology. Doctor Patel has published over 160 peer reviewed manuscripts. She serves on a National Institutes of Health study section and has been a member of the ICAAC/IDSA Program Planning Committee. She is an associate editor for the Journal of Clinical Microbiology.

Return to the top

Time: 1615-1815

Speaker: Professor Soeren G Gatermann

Presentation title: Staphylococcus saprophyticus: virulence mechanism and forms of disease

S. Gatermann studied Medicine in Hamburg, Germany, and specialized in Medical Microbiology at the universities of Hamburg and Lübeck, Germany. Main interests are virulence factors and disease mechanisms of coagulase-negative staphylococci, in particular of S. saprophyticus. A second major research interest is the relevance and detection of resistance mechanisms in grampositive and gramnegative pathogenic microorganisms.

Return to the top

Time: 1615-1815

Speaker: Professor Dietrich Mack, Chair of Medical Microbiology and Infectious Diseases, Microbiology and Infection, Institute of Life Science (Level 5), School of Medicine, Swansea University

Presentation title: Staphylococcus epidermidis virulence factors in various forms of device related infection

Prof Mack holds the Chair in Medical Microbiology and Infectious Diseases at Swansea University’s School of Medicine since 2004 and is an Honorary Consultant Microbiologist at NPHS Microbiology Laboratory Swansea. Before he was Professor of Medical Microbiology and Hospital Hygiene at Hamburg University, Germany. His major research interests are pathogenesis of biomaterial-associated infection, staphylococcal biofilm formation, antibiotic resistance mechanisms like MRSA and ESBL, and rapid identification and typing of nosocomial microorganisms using molecular technology like real-time PCR, mass spectrometry and Raman spectroscopy.

Return to the top

Time: 1615-1815

Speaker: Assistant Professor Vivian H Chu, Assistant Professor of Medicine, Division of Infectious Diseases, Duke University Medical Center, Durham, North Carolina U.S.A

Presentation title: Epidemiology and genomics of coagulase-negative staphylococci causing infective endocarditis

Dr. Chu is an assistant professor in the Division of Infectious Diseases at Duke University Medical Center, Durham NC, U.S.A. Dr. Chu received her medical degree from Columbia University, New York; and completed her residency in Internal Medicine and a fellowship in Infectious Diseases at Duke University Medical Center. Dr. Chu’s research focuses on coagulase-negative staphylococcal (CNS) infections. Dr. Chu is a recipient of the American Heart Association career development award, 2006.

Return to the top

Time: 1615-1815

Speaker: Dr Matthias Helble, Technical Officer, Trade, Foreign Policy, Diplomacy and Health Unit, Department of Ethics, Equity, Trade and Human Rights, World Health Organization

Presentation title: Movement of patients across international borders - emerging challenges and opportunities for health care systems

Dr Helble is working as Technical Officer for the World Health Organization. He is currently responsible for various projects in the area of trade and health. Before joining WHO, he worked for the World Bank as well as for the World Trade Organization. Dr Helble has published widely in the field of trade and health. He has contributed to various books and reports and his paper appeared in prominent scientific journals such as World Economy, Journal of World Trade, and Review of World Economics. Dr Helble earned his PhD International Relations with a specialization in International Economics at the Graduate Institute of International Studies in Geneva.

Return to the top

Time: 1630-1800

Speaker: Dr Ivor Byren, Lead Consultant, Bone Infection Unit, Nuffield Orthopaedic Centre

Presentation title: Introduction

Dr Byren provides the medical leadership to the Bone Infection Unit having trained in South Africa, New Zealand, USA and UK. Dr Byren Chairs the Guidelines writing committee for Bone and Joint Infections on behalf of the BIS/AMM/BOA.

Return to the top

Time: 1630-1800

Speaker: Dr Bridget Atkins, Consultant Microbiology/Infectious Diseases. Physician Bone Infection Unit. Oxford Radcliffe Hospitals and Nuffield Orthopaedic Centre, Oxford.

Presentation title: Prevention – can we?

Qualified 1987, Cambridge/Royal London. House officer, SHO rotation and first registrar post in London. Most specialty training was in Oxford, but also two and a half years ID/HIV in Sydney. Consultant in ID/Micro/Bone Infection unit (BIU) in Oxford since 2000. Deputy clinical lead BIU. ID/Micro Programme Director, Oxford Deanery.

Return to the top

Time: 1630-1800

Speaker: Dr Saul Faust, Senior Lecturer in Paediatric Infectious Diseases, University of Southampton

Presentation title: Complexity vs simplicity in children -Joint presentation with Dr Ed Moran

Saul N. Faust MRCPCH PhD FHEA is Senior Lecturer in Paediatric Infectious Diseases & Immunology and Director of the Wellcome Trust Clinical Research Facility at the University of Southampton. His current research interests include the pathophysiology and treatment of paediatric and neonatal sepsis and he is chief investigator of a phase II multicentre study of corticosteroids in paediatric sepsis. Current projects also include work to bridge the clinical-laboratory interface in paediatric infectious diseases and respiratory medicine, and in and in developing local and national clinical trials in paediatric infectious diseases and infection control.

Return to the top

Time: 1630-1800

Speaker: Dr Alastair Miller, Consultant in Infectious Disease, Royal Liverpool University Hospital

Presentation title: Metalwork: Throw it away or save it for a rainy day?
(Joint presentation with Dr Ed Moran & Dr Frances Sanderson)

Alastair Miller is Consultant Physician at the Tropical and Infectious Diseases Unit, Royal Liverpool University Hospital, where his
main interests are co-infection of HIV/hepatitis and management of bone & joint infection. He trained at Cambridge & Westminster and did ID training in Birmingham & London. He is Chair of the SAC on Infectious Disease

Return to the top

Time: 1630-1800

Speaker: Dr Johan W. Mouton, Consultant-Microbiologist, Canisius Wilhelmiina Hospital

Presentation title: Basic tools and dynamics of PK/PD

Dr Johan W. Mouton is a consultant clinical microbiologist at the Regional Public Health Laboratory located at the Canisius Wilhelmina Hospital in Nijmegen. Prior to this position, he was a consultant clinical microbiologist at the University Hospital Dijkzigt and the Sophia's Children's Hospital in Rotterdam, The Netherlands. His major areas of research include pharmacodynamics and anti-infective pharmacology – in particular in relation to optimising efficacy and reducing the emergence of resistance – and the emergence of resistance in pneumococci. He chairs the Dutch Committee of Antimicrobial Susceptibility Testing (CRG) and is a member of the European Steering Committee of Antimicrobial Susceptibility Testing (EUCAST). Between 2002 and 2004 he was President of the International Society of Anti-infective Pharmacology. Dr Mouton is editor and/or a member of the editorial board of a number of Journals focused on infectious diseases and antimicrobial chemotherapy . He has published over 190 papers in peer-reviewed journals and over 300 abstracts at scientific meetings. .

Return to the top

Time: 1630-1800

Speaker: Professor Peter Lees, Professor of Veterinary Pharmacology, Royal Veterinary Collegeic Centre

Presentation title: PK / PD: A veterinary perspective

Peter Lees joined the staff of the Royal Veterinary College, London University, in 1964 and was appointed to the chair of Veterinary Pharmacology in 1988. He has served periods as Head of Department of Veterinary Basic Sciences, Vice Principal for Teaching and Deputy Principal. He served for 13 years as Editor of Journal of Veterinary Pharmacology and Therapeutics and as a member of the Veterinary Products Committee for 20 years. His research interests have varied widely from anaesthetic and ancillary agents to anti-arthritic drugs. For many years his principal research activities have been the pharmacology (pharmacokinetics and pharmacodynamics) of antimicrobial and anti-inflammatory drugs in several species of particular veterinary interest.

Return to the top

Time: 1630-1800

Speaker: Professor Alasdair MacGowan, Professor of Clinical Microbiology & Antimicrobial Therapeutics

Presentation title: Mini debate: The cases for and against clinical relevance of PK / PDbr

Alasdair MacGowan is Professor of Clinical Microbiology & Antimicrobial Therapeutics at the University of Bristol, and Consultant Medical Microbiologist and Head of Research & Specialist Services in the Department of Medical Microbiology at North Bristol NHS Trust. He trained in infection in Aberdeen, Birmingham and Bristol, and is a Fellow of the Royal Colleges of Physicians (Edinburgh) and Pathologists (UK). He is past President of the British Society for Antimicrobial Chemotherapy (BSAC), and BSAC representative on the European Committee on Antimicrobial Susceptibility Testing (EUCAST). His main research interests are in antibiotic resistance epidemiology in the community, and antibacterial pharmacokinetics/pharmacodynamics.

Return to the top

Time: 1630-1800

Speaker: Dr Kieran Hand, Consultant Pharmacist, Anti-infectives, Southampton University Hospitals NHS Trust

Mini debate: The cases for and against clinical relevance of PK / PD

Dr Kieran Hand is a hospital pharmacist with a PhD in pharmacology and an MSc in Infection Management from Imperial College London. Kieran has worked in a specialist infection management role in the NHS for eight years and was appointed to the first UK consultant pharmacist post in the infectious diseases speciality at Southampton in 2007. Kieran is an editor at the Journal of Antimicrobial Chemotherapy, a member of BSAC Council and represents pharmacists on the Health Protection Agency programme board for healthcare associated infection and antimicrobial resistance.

Return to the top

Time: 1815-1915

Speaker: Dr Jane Stockley, Consultant Medical Microbiologist, Worcestershire Royal Hospital

Presentation title: Using the Appraisal of Guidelines Research & Evaluation (AGREE) instrument - The SpR Review Group

Jane Stockley is a member of the BIS Clinical Guidelines Group, and has an interest in medical education. Her clinical interests include infection in immunocompromised patients, and the infection control aspects of new hospital builds.

Return to the top

Time: 1815-1915

Speaker: Dr Mary Ashcroft, Consultant Microbiologist, Royal Wolverhampton Hospital NHS Trust

Presentation title: Using the Appraisal of Guidelines Research & Evaluation (AGREE) instrument - The SpR Review Group

I have recently completed my training as a microbiology specialist registrar in the West Midlands Deanery. I am now a part-time Consultant at New Cross Hospital, Wolverhampton.

Return to the top

Time: 1815-1915

Speaker: Dr Sarjana Jain, SpR Microbiology, University Hospitals Birmingham NHS Trust

Presentation title: Using the Appraisal of Guidelines Research & Evaluation (AGREE) instrument - The SpR Review Group

I am a final year microbiology specialist registrar, currently working at University Hospitals Birmingham

Return to the top

Time: 1815-1915

Speaker: Dr Anna Last, SpR Infectious Diseases, Tropical Medicine & General Internal Medicine, Worcestershire Acute Hospitals NHS Trust

Presentation title: Using the Appraisal of Guidelines Research & Evaluation (AGREE) instrument - The SpR Review Group

Graduated from Birmingham Medical School in 2003 with MBChB and BmedSc (1st class hons) in Public Health and Epidemiology (dissertation research on prevention and control strategies for malaria in pregnancy in The Gambia). Completed MRCP in 2006. Completed DTM&H at the Liverpool School of Tropical Medicine & Hygiene in 2007. Obtained NTN in Infectious Diseases, Tropical Medicine & GIM in the West Midlands. Honorary MRC Clinical Research Fellow for the Brain Infections Group at the University of Liverpool in 2007 (research into the roles of pro-inflammatory cytokines in the pathogenesis of Japanese Encephalitis in Karnataka, India). Currently a 3rd year SpR in Infectious Diseases & GIM in the Worcestershire Acute Hospitals NHS Trust.

Return to the top

Time: 1815-1915

Speaker: Mr Keith Pollard, Managing Director, Treatment Abroad

Presentation title: The UK, the EU, the World – and the public-private interface in medical tourism

Keith Pollard is Managing Director of Intuition Communication, an online publisher in the healthcare sector that operates market-leading web portals such as Private Healthcare UK, Surgery Door, the Harley Street Guide, and medical tourism sites such as Treatment Abroad. Intuition also publishes IMTJ – International Medical Travel Journal - an online business to business resource for the medical travel and medical tourism markets. Keith is one of Europe’s leading experts on medical tourism. His company has initiated a Code of Practice for Medical Tourism and has sponsored research into various aspects of medical travel.

Return to the top

Time: 1815-1915

Speaker: Dr Mitul Patel, Consultant Medical Microbiologist, Birmingham Children’s Hospital

Discussion title: Using the Appraisal of Guidelines Research & Evaluation (AGREE) instrument - The SpR Review Group

Return to the top

Time: 1815-1915

Speaker: Dr Rosemary Barnes, Reader/Consultant Microbiologist, Cardiff Uiversity

Discussion title: Using the Appraisal of Guidelines Research & Evaluation (AGREE) instrument - The SpR Review Group

Rosemary Barnes is Clinical Reader and head Medical Microbiologist at the School of Medicine at Cardiff University. She qualified from Cambridge University and Westminster Medical School. Her interests include infections in immunocompromised patients and diagnosis of invasive fungal infection.

Return to the top

Time: 1815-1915

Speaker: Dr Ali Omrani, Consultant in Infectious Diseases & Microbiology, Royal Glamorgan Hospital

Discussion title: Spiraling antimicrobial empiricism

Dr Ali Omrani trained in Microbiology & Infectious Diseases at Birmingham Heartlands Hospital and the University Hospital of Wales, Cardiff. He is currently based at the Royal Glamorgan Hospital, Wales. His clinical interests include antimicrobial stewardship, skin and soft tissue infections, viral hepatitis and HIV/AIDS.

Return to the top

Time: 1100-1230

Speaker: Dr Frank Rijsberman, Director Program, Google.org, philanthropic arm of Google Inc

Presentation title: Can we predict and prevent the next pandemic?

Dr Frank Rijsberman joined Google.org, the philanthropic arm of Google Inc., in June 2007, where he is Director Program, responsible for the global public health initiative, Predict and Prevent, among others. Prior to joining Google, Frank was Director General (CEO) of the non-profit research institute International Water Management Institute (www.IWMI.org), with HQ in Sri Lanka. Rijsberman holds a PhD from Colorado State University in Civil Engineering (Water Resources Planning and Management). He was a Professor at UNESCO-IHE International Institute for Water Education in the Netherlands from 1999-2008, jointly appointed at Wageningen University from 2003-8.

Return to the top

Time: 1100-1230

Speaker: Professor Neil Ferguson, Director, MRC Centre for Outbreak Analysis and Modelling, Imperial College London

Presentation title: Real time modeling and analysis of the H1N1 ‘Swine’ influenza pandemic

Neil Ferguson uses mathematical and statistical models to investigate the processes shaping infectious disease pathogenesis, evolution and transmission. He has undertaken applied research on influenza, SARS, BSE/vCJD, HIV and foot-and-mouth disease (FMD). He is a Fellow of the UK Academy of Medical Sciences and received an OBE in 2001 for his work on the foot and mouth disease epidemic that year. He has recently focussed on modelling pandemic influenza, bioterrorist threats and livestock infections (FMD and avian influenza). Dr Ferguson advises the UK, US and Chinese governments and the World Health Organisation on the management of the current ‘Swine’ influenza pandemic.

Return to the top

Time: 1100-1230

Speaker: Professor Mark Wilcox, Consultant / Clinical Director of Microbiology/Pathology (Leeds Teaching Hospitals NHS Trust), Professor of Medical Microbiology (University of Leeds), Health Protection Agency Lead on Clostridium difficile

Mini keynote presentation: Surgical prophylaxis in an age of MRSA

Professor Mark Wilcox is a Consultant Microbiologist, Head of Microbiology, and Clinical Director of Pathology, at the Leeds Teaching Hospitals, Professor of Medical Microbiology at the University of Leeds, and is the Lead on Clostridium difficile for the Health Protection Agency in England.
He was the Scientific Chairman of the 2002 Hospital Infection Society International Conference and is a former Secretary of the Hospital Infection Society, Assistant Editor of the Journal of Antimicrobial Chemotherapy and member of Council of the British Society of Antimicrobial Chemotherapy.
Professor Wilcox is a member of the UK Department of Health’s Antimicrobial Resistance and Healthcare Associated Infection (ARHAI) Committee, the HPA’s Programme Board on Healthcare Associated Infection & Antimicrobial Resistance, and is an advisor to the UK Healthcare Commission, the UK Medicines and Healthcare products Regulatory Agency, the EPIC project, the Health Technology Assessment (HTA) programme on Healthcare Associated Infection, the Wellcome Trust and the European Centre for Disease Control. He is a member of UK, European and US working groups on Clostridium difficile infection.

Return to the top

Time: 1100-1230

Speaker: Professor S Homer-Vanniasinkam BSc MD FRCSED FRCS

Mini keynote presentation: High risk vascular procedures into poorly vascularized tissue
Case presentation: Infected prosthetic graft

Professor Shervanthi Homer-Vanniasinkam was appointed Consultant Vascular Surgeon at The General Infirmary at Leeds in October 1995. In June 2008 she was awarded a Personal Chair in Clinical and Experimental Vascular Research by the University of Bradford; in 2006, she was appointed to the first Chair in Translational Vascular Medicine at Bradford. In September 2008, she was appointed Director of Research and Education at the Northwick Park Institute for Medical Research (affiliated to University College London; UCL) in London, and was invited to accept an Honorary Chair in Surgery, at UCL.

Return to the top

Time: 1500-1800

Speaker: Dr Keith Perry, Unit Head, Health Protection Agency

Presentation title: How to evaluate a new test prior to introduction into routine service

Keith Perry is a Clinical Scientist based at the Health Protection Agency. He has worked in a hospital laboratory in Zambia (1982-1985); was involved in the early development of assays to detect virus-specific antibodies in non-invasive oral fluid specimens (1986-1994); and worked on a range of evaluation topics related to microbiology with an interest in supporting the uptake of high performance kits and equipment (1995-2009). He is now leading a new high throughput molecular diagnostics laboratory with the current focus on Influenza H1N1.

Return to the top

Time: 1500-1800

Speaker: Dr Stephanie Dancer, Consultant Microbiologist, NHS Lanarkshire

Presentation title: How to review a scientific paper for a journal

Formerly a consultant microbiologist at the Southern General Hospital in Glasgow (2005-7), Stephanie now works in NHS Lanarkshire and is the current editor of the Journal of Hospital Infection. She trained at St Bartholomew's hospital in London followed by postgraduate studies at Guy's hospital, where she gained a thesis on the epidemiology and biochemistry of toxin-producing staphylococci. She has worked in various remote areas of the world, including Papua New Guinea, Thailand, Vietnam and the Canadian High Arctic, where she resuscitated 30,000 year old organisms from glacial ice. At present she balances clinical and editorial duties with various research projects, specifically the role of antibiotics, screening and cleaning in the control of MRSA.

Return to the top

Time: 1500-1800

Speaker: Ruth Gibson, Head of Risk Management, Sandwell and West Birmingham Hospitals NHS Trust

Presentation title: How to undertake a root cause analysis for an infection control related incident

Ruth has worked in risk management within the NHS for 6 years. Prior to this she was a practicing clinical negligence solicitor. Whilst her experience was mainly in defending claims against hospitals, she spent a brief time acting for claimants, helping to gain an understanding of both sides of the fence.

Return to the top

Time: 1500-1800

Speaker:Mr Richard Kirby, Chief Operating Officer, Sandwell and West Birmingham Hospitals NHS Trust

Presentation title: Producing Good Business Cases – How to Get Your Ideas Approved!

After graduating from Oxford University, Richard joined the NHS Management Training Scheme in the West Midlands. The scheme led to a series of jobs in commissioning and performance management in the NHS in Birmingham before Richard joined SWBH initially as Director of Strategy and most recently as Chief Operating Officer.

Return to the top

Time: 1500-1800

Speaker: Dr Mark Farrington, Consultant Medical Microbiologist & Clinical Services Director, Health Protection Agency, Addenbrooke’s Hospital

Presentation title: The role of prophylaxis and emerging technologies in the management of surgical infections

Dr Mark Farrington was appointed as Consultant Microbiologist at Addenbrooke’s Hospital, Cambridge in 1987. He was Lead Clinician for Clinical Audit & Effectiveness 1997-2002 and Clinical Director for Pathology 2002-2007. Special interests include hospital Infection Control (especially of staphylococcal infection), and infection in orthopaedic implant surgery, neurosurgery and in transplant recipients. UK guideline development group memberships include MRSA (published 2006), Surgical Site Infection (NICE, 2008) and Vascular Surgical Infection (BSAC). He has been a Council Member of the UK Hospital Infection Society, and an editorial board member of Infection Control and Hospital Epidemiology and the Journal of Medical Microbiology.

Return to the top

Time: 1630-1800

Speaker: Professor Djillali Annane, Director of the General ICU, Raymond Poincaré hospital (AP-HP)

Presentation title: Steroid therapy: good, bad or what?

Djillali Annane is Professor in medicine at the University of Versailles SQY and the head of the critical care department (46 beds) at Raymond Poincaré University Hospital (AP-HP) in Garches, Paris, France. He has completed MD in 1991, and a PhD in pharmacology in 1995, both at Paris 5 University. His main area of research is the neuroendocrine response to sepsis with a particular interest in the hypothalamic-pituitary adrenal axis and vasopressin, and has led several clinical trials in the field of sepsis and critical care medicine. He has published about two hundred scientific papers including original peer reviewed articles and book chapters.

Return to the top

Time: 1630-1800

Speaker: Prof Mervyn Singer, Professor of Intensive Care Medicine, University College London

Presentation title: Diagnostic and prognostic biomarkers for sepsis and organ injury

Mervyn Singer is Professor of Intensive Care Medicine at UCL and a NIHR Senior Investigator. He is widely published in the field of sepsis, multi-organ failure and infection and runs a research group primarily funded by the MRC and Wellcome Trust.

Return to the top

Time: 1630-1800

Speaker: Dr. David Fedson, Former Professor of Medicine, University of Virginia School of Medicine (-1995) Current residence

Presentation title: Confronting H1N1 influenza with agents that modify the host response; why they are needed and how they might work

Dr. Fedson received his medical degree from Yale in 1965. He trained on the Osler Medical Service at The Johns Hopkins Hospital and at the National Institutes of Health. He was Chief Medical Resident at the University of Chicago and then joined the Department of Medicine. Later, at the University of Virginia, he was Head of the Division of General Medicine and the Harry T. Peters, Jr. Professor of Internal Medicine. He served on U.S. Advisory Committee on Immunization Practices (ACIP; 1984-88) and the National Vaccine Advisory Committee (NVAC; 1990-94). In 1995, he became Director of Medical Affairs for Aventis Pasteur MSD. His research has focused on the epidemiology and cost-effectiveness of influenza and pneumococcal vaccination and, since retiring in 2002, the prospect for using anti-inflammatory and immunomodulatory agents to treat pandemic influenza. He has published more than 160 scientific articles and chapters. He and his wife and 15-year old son live in France, just outside Geneva.

Return to the top

Time: 1630-1800

Speaker: Dr Jonathan Edgeworth, Consultant Microbiologist, Guy’s and St Thomas’ Hospital

Presentation title: The host and bacterial factors that determine outcome from S. aureus bacteraemia

Jonathan Edgeworth is a consultant microbiologist and Director of Pathology at Guy’s and St Thomas’ Hospital and an Honorary Senior Lecturer at King’s College London. He has a PhD in immunology and did basic research on bacterial pathogenesis and innate immunity at Cancer Research UK (London) and Institut Pasteur (Paris), before taking up his current position in 2002. His research interest is in the epidemiology and pathogenesis of hospital-acquired infections, particularly those due to methicillin-resistant Staphylococcus aureus.

Return to the top

Time: 1630-1800

Speaker: Dr Martin Llewelyn, Senior Lecturer and Consultant in Infectious Diseases, Brighton and Sussex Medical School

Presentation title: The Management of S.aureus bacteraemia: what does the evidence and guidelines tell us?

I trained in infectious diseases in North Thames and did a PhD at Imperial College studying the immune response to bacterial superantigens. Since becoming a consultant in 2004 I have become interested in improving the management of healthcare associated infections, particularly S. aureus and C. difficile infection.

Return to the top

Time: 1630-1800

Speaker: Dr Guy Thwaites, Wellcome Trust Clinical Research Fellow, Imperial College

Presentation title: The Management of Staphylococcus aureus bacteraemia: do we practice what we preach?

I am currently a Wellcome Trust Clinical Research Fellow at Imperial College, London and divide my time equally between research and clinical practice. My research interests centre on the clinical management of severe bacterial infections. These include central nervous system infection, in particular tuberculous meningitis, pyogenic bacterial meningitis, and tetanus and, more recently, Staphylococcus aureus bacteraemia. My interests developed whilst working at the Oxford University Clinical Research Unit in Ho Chi Minh City, Vietnam. I qualified from Cambridge University and Guy’s and St Thomas’s Hospital.

Return to the top

Time: 0900-1000

Speaker: Dr Fiona Godlee, Editor in Chief, British Medical Journal

Fiona Godlee has been Editor in Chief of the BMJ since 2005. She qualified as a doctor in 1985, trained as a general physician in Cambridge and London, and is a Fellow of the Royal College of Physicians. Since joining the BMJ in 1990 she has written on a broad range of issues, including the impact of environmental degradation on health, the future of the World Health Organisation, the ethics of academic publication, and the problems of editorial peer review. In 1994 she spent a year at Harvard University as a Harkness Fellow evaluating efforts to bridge the gap between medical research and practice. On returning to the UK, she led the development of BMJ Clinical Evidence, which evaluates the best available evidence on the benefits and harms of treatments and is now provided worldwide to over a million clinicians in 9 languages. In 2000 she moved to Current Science Group to establish the open access online publisher BioMed Central as Editorial Director for Medicine. In 2003 she returned to the BMJ Group to head up its new Knowledge division. She has served as President of the World Association of Medical Editors (WAME) and Chair of the Committee on Publication Ethics (COPE) and is co-editor of Peer Review in Health Sciences. She lives in Cambridge with her husband and two children.

Return to the top

Time: 1100-1230

Speaker: Mr Tom Lloyd, Director, PearsonLloyd

Presentation Title: Deconstructing the commode

Tom is a Director of the London design studio PearsonLloyd. He trained in Furniture Design at Nottingham, before completing an MA in Industrial Design at the RCA in 1993. Following three years working with Daniel Weil at Pentagram, Tom joined Luke Pearson to found PearsonLloyd in 1997. The studio’s work focuses on design for manufacture in the fields of furniture, transport design and the public realm and has a reputation for producing modern designs that combine aesthetic clarity with functional and technological innovation. Most recently Tom Lloyd has been awarded with the distinction of Royal Designer for Industry by the RSA.

Return to the top

Time: 1100-1230

Speaker: Dr Bryan Griffiths, Programme Director for Smart Solutions, TrusTECH, NW Innovation Hub

Presentation Title: Smart Solutions – the search for novel product to help combat HCAIs

Dr Bryan Griffiths is Business Development Manager for TrusTECH, the North West Innovation Hub and Programme Director for Smart Solutions for HCAI.

Previously Bryan worked at ConvaTec and was involved the design and development of medical devices from inception to launch, achieving successful global commercialisation of a number of wound care products.

Bryan has been the head of commercial services for TrusTECH since 2007 and during that time the department has grown and attracted a number of key commercial clients and associates with innovative healthcare projects some of which are now in trial across the North West.

Bryan became Programme Director for Smart Solutions for HCAI in 2008.

Return to the top

Time: 1100-1230

Speaker: Professor Brian Duerden

Presentation Title: Overview (10 minutes)

Professor Brian Duerden CBE is the Inspector of Microbiology and Infection Control at the Department of Health, and emeritus Professor of Medical Microbiology at Cardiff University. Graduating from Edinburgh University in 1972, he was a Lecturer in Edinburgh and Lecturer, Senior Lecturer and then Professor of Medical Microbiology in Sheffield University. In 1991 he moved to Cardiff as Professor and Director of the Cardiff PHL. He was Deputy Director/Medical Director of the PHLS 1995-2002 and PHLS Director until becoming Director for Clinical Quality in the HPA and then moving to DH in 2004. He was awarded CBE in 2008.


Return to the top

Time: 1100-1230

Speaker: Dr Peter Wilson, Consultant Microbiologist, University College London Hospitals

Presentation Title: Pilot study of novel solutions to bring source isolation to the ward patient

Dr Peter Wilson is a consultant microbiologist at University College London Hospitals. He has particular responsibility for antimicrobial advice in critical care and surgery as well as infection control in the hospital and the community. He has been involved in research in hospital-acquired infection for the last 25 years, particularly treatment and prevention of spread of MRSA .


Return to the top

Time: 1100-1230

Speaker: Professor Paul Boyle, Professor of Human Geography & Director of the Longitudinal Studies Centre – Scotland (LSCS), University of St Andrews

Presentation Title: The effect of migration on health inequalities

Paul Boyle is Professor of Human Geography and Head of the School of Geography and Geosciences at the University of St Andrews. He is President of the British Society for Population Studies (BSPS). He directs the Longitudinal Studies Centre - Scotland (LSCS), which has established and continues to maintain and support the Scottish Longitudinal Study (SLS), which is one of the world’s largest longitudinal datasets for health and social science research. He is co-Director of the recently funded ESRC Centre for Population Change (CPC); co-applicant on the recently funded ESRC Administrative Data Liaison Service (ADLS); and co-applicant on the Wellcome Trust Scottish Health Informatics Programme (SHIP). Paul has particular expertise in record linkage and the use of routinely collected data in health and social science research. He has published widely in demography and epidemiology.

Return to the top

Time: 1100-1230

Speaker: Professor Kenneth Rockwood, FRCPC, FRCP, Professor of Medicine (Geriatric Medicine & Neurology), Dalhousie University, Halifax, Nova Scotia CANADA, Consultant Physician, Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, CANADA

Presentation Title: Consequences and assessment of frailty in older people

Dr. Kenneth Rockwood has had a longstanding interest in dementia and delirium. He is a leading authority on frailty, focusing his investigations on the complexity of frailty, and what can be termed “clinic-mathematical correlation”. He has published six books and more than 250 peer-reviewed scientific publications. Currently, he is co-editor of the 7th edition of the Brocklehurst’s Textbook of Geriatric Medicine & Gerontology. He is the principal investigator of the Canadian Dementia Knowledge Translation Network, a national, multicentre project to provide better care for people with dementia by facilitating

Return to the top

Time: 1100-1230

Speaker: Dr Stephen Gallacher, Consultant Physician, Southern General Hospital, Glasgow

Presentation Title: Obesity – A Public Health Pandemic

Dr Gallacher is Consultant Physician with an interest in Diabetes & Endocrinology based at the Southern General Hospital, Glasgow. Dr Gallacher qualified from the University of Glasgow in 1983 and was appointed as Consultant Physician in 1995. Dr Gallacher has a sub-specialty interest in Osteoporosis and Metabolic Bone Disease stretching back many years. Dr Gallacher has published many papers in peer reviewed journals on the subject of diabetes, osteoporosis and other metabolic diseases.

Return to the top

Time: 1250-1350

Speaker: Professor Roger Finch, Professor of Infectious Diseases, Nottingham University Hospitals and University of Nottinghams

Presentation Title: UK Priorities

Roger Finch is Professor of Infectious Diseases at the University of Nottingham. He has published some 350 articles covering the fields of antimicrobial chemotherapy, respiratory tract infections and the pathogenesis of staphylococcal disease. He is co-editor of “Antibiotic and Chemotherapy” (8th ed); European Editor of Current Opinion in Infectious Diseases and formerly Editor-in-Chief of the Journal of Antimicrobial Chemotherapy.

Professor Finch Chairs the UK Advisory Committee on Antimicrobial Resistance & Healthcare Associated Infections (ARHAI) and advises the European Commission, the Committee on Proprietary Medicinal Products and the European Centre for Disease Prevention & Control. He was formerly President of the British Infection Society, Chairman of the Federation of Infection Societies and President of the European Society of Clinical Microbiology and Infectious Diseases.

Return to the top

Time: 1250-1350

Speaker: Dr Herman Goossens, Director of Clinical Pathology Laboratory, University Hospital Antwerp

Presentation title: ESAC European Overview

Herman Goossens is Professor at the University of Antwerp, Belgium. He is the Head of the Laboratory of Microbiology and the Department of Clinical Pathology at the University Hospital of Antwerp. Prof. Goossens published more than 300 full papers in peer-reviewed scientific journals and 25 chapters in textbooks. He has several expert positions in Belgian, EU, USA, and WHO official organisations. He was a member of the ICAAC Program Committee from 2001 to 2005. He is the co-ordinator of several European projects funded by the European Commission, including the European Surveillance of Antibiotic Consumption (ESAC, 2001-2010), and Genomics to Combat Resistance against Antibiotics in Community-acquired LRTI in Europe (GRACE, 2006 – 2011). Prof. Goossens was the organiser of the European Conference on Antibiotic Use in 2001 on behalf of the Belgian EU Presidency, of the International Workshop on Educational Campaigns regarding antibiotic resistance in 2004, and of the European Workshop on indicators for quality prescribing in primary care in 2005.

Return to the top

Time: 1250-1350

Professor Peter Davey, Lead Clinician for Quality Improvement, University of Dundee

Presentation title: ESAC hospital care data, comparison of UK with Europe

Peter Davey is Professor in Pharmacoeconomics and Lead Clinician for Quality Improvement at the University of Dundee. He is an Honorary Consultant Physician in Infectious Diseases and his research interests are in antimicrobial stewardship, quality improvement and patient safety. He is Vice President of BSAC, Education Secretary of BSAC and the lead for the Hospital Care Subproject of ESAC (European Surveillance of Antimicrobial Consumption)

Return to the top

Time: 1250-1350

Speaker: Dr Hayley Wickens, Senior Lead Pharmacist, Antibiotic Audit and Research, Imperial College Healthcare NHS Trust (& BSAC)

Presentation Title: ESAC Ambulatory care data, comparison of UK with Europe and key trends

Hayley Wickens is Senior Lead Pharmacist, Antibiotic Audit and Research at Imperial College Healthcare NHS Trust. She graduated in pharmacy in 1994, working in hospital pharmacy and broadcast media before completing a PhD in Pharmaceutical Microbiology and rejoining the NHS in 2001. Hayley was a founder committee member of the UK Clinical Pharmacy Association Infection Management Group, is on the Management Committee for the Imperial MSc in Infection Management for Pharmacists, and works part-time for BSAC collating ESAC data for the UK.

Return to the top

Time: 1400-1500

Speaker: Dr Tyrone Pitt, Formerly Deputy Director,Laboratory of Healthcare Associated Infection, HPA Centre for Infections

Presentation title: The enigma of Pseudomonas aeruginosa in the lungs of people with cystic fibrosis – a case of natural selection?

FIMLS 1973; MPhil 1977, PhD 1980. Head of Epidemiological Typing Unit and Deputy Director of the Laboratory of HealthCare Associated Infection until March 2009. Honorary Senior Lecturer at the LSH&TM and CF Department, NHLI, Royal Brompton Hospital. Consultant to the National Transfusion Microbiology Laboratory of the NBS Service. Advisor to the UK Stem Cell Bank. Member of DH committee on Safety of Blood Tissues and Organs (SaBTO) Interests: microbiology of lung infections in people with cystic fibrosis; epidemiology of bacterial opportunists; safety of blood and tissues for transplantation Author of 140+ papers, several invited articles. Associate Editor, Epidemiology and Infection

Return to the top

Time: 1500-1600

Speaker: Dr Maxine Power, Director, North West Improvement

Presentation Title: Using social movement campaigns to reduce infection – experience of the English Patient Safety Campaign

Maxine is the Director of the North West Improvement Alliance, a newly formed stakeholder organisation which will help NW organisations to achieve transformational improvements in the care they deliver through building improvement capability. Before that, she was Associate Director of Quality Improvement at Salford Royal NHS Foundation Trust and led the Quality Improvement Directorate which provides organisational support to assist teams with quality improvement. She is a core member of the National Patient Safety Campaign for England.

Return to the top

Time: 1500-1600

Professor Doctor Uwe Frank, Clinical Microbiologist, University Medical Center of Freiburg

Presentation title: Informing the public about antimicrobial resistance

Uwe Frank, MD, PhD is Professor of Clinical Microbiology at the Medical School, Freiburg University Hospital, Germany. He was workpackage leader in the European IPSE/HELICS project (Improving Patient Safety in Europe/Hospital in Europe Link for Infection Control through Surveillance) and coordinator of the BURDEN project (Burden of Resistance and Disease in European Nations), both of which were financed by the EU Commission Directorate-General for Health and Consumer Protection (DG SANCO).

Return to the top

Time: 1500-1600

Speaker: Professor Ian R Poxton, Professor of Microbial Infection and Immunity, University of Edinburgh

Presentation title: Clostridium difficile – the unwelcome guest

Worked through the ranks in Edinburgh from appointment as Lecturer in Bacteriology in 1977 to award of personal chair in 1999. Major interest in Clostridium difficile since 1979 and recently finished 4-year term (2005-2009) as Chair of the ESCMID European Study Group for Clostridium difficile. Other interests past and present include other pathogenic clostridia and anaerobic bacteria in general, Gram-negative pathogens and their endotoxins, and host responses to bacterial infections. Formerly Editor-in-chief of the Journal of Medical Microbiology (2003-2007).

Return to the top

Time: 1500-1600

Speaker: Dr Saul Faust, Senior Lecturer in Paediatric Infectious Diseases & Immunology and Director of the Wellcome Trust Clinical Research Facility at the University of Southampton.

Presentation title: Disconnecting for Health: the way forward using integrated solutions
t

Saul N. Faust MRCPCH PhD FHEA is Senior Lecturer in Paediatric Infectious Diseases & Immunology and Director of the Wellcome Trust Clinical Research Facility at the University of Southampton. His current research interests include the pathophysiology and treatment of paediatric and neonatal sepsis and he is chief investigator of a phase II multicentre study of corticosteroids in paediatric sepsis. Current projects also include work to bridge the clinical-laboratory interface in paediatric infectious diseases and respiratory medicine, and in developing local and national clinical trials in paediatric infectious diseases and infection control.

Return to the top

Time: 1500-1600

Speaker: Professor John Starr, Professor of Health & Ageing, University of Edinburgh

Presentation title: Clostridium difficile – the hospitable host

John Starr is an NHS consultant and Honorary Professor of Health & Ageing at the University of Edinburgh. He has a longstanding interest in Clostridium difficile infection. Using stochastic modelling data on potential impact of reducing host susceptibility and environmental cleansing, he applied the findings to formulate an infection control policy that has reduced infection rates by 50% over the last 2 years.

Return to the top

Time: 1500-1600

Session chair: Dr Andrew Pearson, Consultant Epidemiologist and Acting Head of HCAI & AMR Dept.

Presentation title: Data mining technology: the strategic options

Consultant Epidemiologist in HCAI/AMR department at CfI wth lead responsibility for development and management of web enabled interactive reporting system for mandatory surveillance of MRSA bacteraemia and C.difficile infections.

London University Diploma in Bacteriology (1974); MSc in epidemiology and statistics London School of Tropical Medicine (MSc.1987), and a MSc in public health from London University in 1996.

Work experience in hospital infection control and information technology was gained through appointments in Southampton University Hospital and Guys & St Thomas’ Trust, as Chairman of PHLS MICROLAB project DH Assessment of IC systems, (ASEPTIC) and as Professor in the faculty of Advanced Computational Biology in Maryland University (USA).


Return to the top

Time: 1500-1600

Session chair: Dr Rod Warren, Lead Consultant Microbiologist, Shrewsbury & Telford Hospital NHS Trust

Presentation title: The Shrewsbury and Telford experience: using an automated solution to integrate PAS, microbiology and hospital prescribing information

Rod Warren, aged 60, lead consultant microbiologist Shrewsbury & Telford Hospital NHS Trust and honorary microbiologist Robert Jones and Agnes Hunt Orthopaedic Hospital, Oswestry. Formerly Group Director PHLS Midlands and district consultant microbiologist at Cambridge. Past Hon Treasurer & member of council, BSAC, and past member Editorial Board Drug & Therapeutics Bulletin. Long term interests in laboratory computerisation and surveillance and diagnosis of hospital-acquired and emerging infections.


Return to the top

Time: 1600-1700

Speaker: Fiona Godlee, Editor in Chief, British Medical Journal

Fiona Godlee has been Editor in Chief of the BMJ since 2005. She qualified as a doctor in 1985, trained as a general physician in Cambridge and London, and is a Fellow of the Royal College of Physicians. Since joining the BMJ in 1990 she has written on a broad range of issues, including the impact of environmental degradation on health, the future of the World Health Organisation, the ethics of academic publication, and the problems of editorial peer review. In 1994 she spent a year at Harvard University as a Harkness Fellow evaluating efforts to bridge the gap between medical research and practice. On returning to the UK, she led the development of BMJ Clinical Evidence, which evaluates the best available evidence on the benefits and harms of treatments and is now provided worldwide to over a million clinicians in 9 languages. In 2000 she moved to Current Science Group to establish the open access online publisher BioMed Central as Editorial Director for Medicine. In 2003 she returned to the BMJ Group to head up its new Knowledge division. She has served as President of the World Association of Medical Editors (WAME) and Chair of the Committee on Publication Ethics (COPE) and is co-editor of Peer Review in Health Sciences. She lives in Cambridge with her husband and two children.

Return to the top